(Q37810522)

23 August 2017

title

β-Arrestins: multifunctional signaling adaptors in type 2 diabetes (English)

1 reference

23 August 2017

0 references

Xiaotao Feng

1

1 reference

23 August 2017

Wenjian Wang

series ordinal

2

1 reference

23 August 2017

Jibo Liu

series ordinal

3

1 reference

23 August 2017

Yi Liu

series ordinal

4

1 reference

23 August 2017

publication date

18 November 2010

1 reference

Molecular Biology Reports

23 August 2017

published in

1 reference

23 August 2017

volume

38

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

2517-2528

1 reference

Light-regulated binding of rhodopsin kinase and other proteins to cattle photoreceptor membranes

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

The structural basis of arrestin-mediated regulation of G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Lipid induced overexpression of NF-kappaB in skeletal muscle cells is linked to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Arrestins: ubiquitous regulators of cellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

X-ray crystal structure of arrestin from bovine rod outer segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Crystal structure of cone arrestin at 2.3A: evolution of receptor specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Activation-dependent conformational changes in {beta}-arrestin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Structure and function of the visual arrestin oligomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Concentration-dependent tetramerization of bovine visual arrestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

β-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Ubiquitin ligase adaptors: regulators of ubiquitylation and endocytosis of plasma membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Modification of proteins by ubiquitin and ubiquitin-like proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

A field guide to ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Polyubiquitin chains: functions, structures, and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Insulin and insulin-like growth factor I receptors utilize different G protein signaling components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

{beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Partially deglycosylated equine LH preferentially activates beta-arrestin-dependent signaling at the follicle-stimulating hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

A beta-arrestin 2 signaling complex mediates lithium action on behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Insulin action under arrestin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Insulin resistance: beta-arrestin development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

S-Adenosyl-L-methionine ameliorates TNFalpha-induced insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Pollen Typhae total flavones inhibit expression of interleukin-6 in C2C12 skeletal muscle cells cultured with palmitate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Effect of opioid mu-receptors activation on insulin signals damaged by tumor necrosis factor alpha in myoblast C2C12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Fenoterol, a beta(2)-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory cytokines production through beta-arrestin-2 in THP-1 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

beta-Arrestins modulate Adenovirus-vector-induced innate immune responses: differential regulation by beta-arrestin-1 and beta-arrestin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Mechanisms of action of glucagon-like peptide 1 in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Overexpression of PACAP in transgenic mouse pancreatic beta-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Dose-response effect of elevated plasma free fatty acid on insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Muscular diacylglycerol metabolism and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Diacylglycerol-mediated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Long chain coenzyme A esters activate the pore-forming subunit (Kir6. 2) of the ATP-regulated potassium channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta-cell line (beta HC9).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Decreased insulin secretion and accumulation of triglyceride in beta cells overexpressing a dominant-negative form of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Tumor necrosis factor receptor-1 can function through a G alpha q/11-beta-arrestin-1 signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFalpha in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

beta-Arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Genetic mapping of the ?-arrestin 1 and 2 genes on mouse Chromosomes 7 and 11 respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0389-3

Enhanced morphine analgesia in mice lacking beta-arrestin 2

21 January 2018

1 reference

12 December 2020

Glucagon-like peptide-1 and energy homeostasis

1 reference

12 December 2020

IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance.

1 reference

12 December 2020

Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s)

1 reference

12 December 2020

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

1 reference

12 December 2020

Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade

1 reference

12 December 2020

Evaluation of the degree of vascular inflammation in patients with metabolic syndrome

1 reference

12 December 2020

Intra-islet PACAP protects pancreatic β-cells against glucotoxicity and lipotoxicity

1 reference

12 December 2020

beta-Arrestin 2: a Negative Regulator of Inflammatory Responses in Polymorphonuclear Leukocytes

1 reference

12 December 2020

Glucose-induced preproinsulin gene expression is inhibited by the free fatty acid palmitate

1 reference

12 December 2020

Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes

1 reference

12 December 2020

Light-induced binding of 48-kDa protein to photoreceptor membranes is highly enhanced by phosphorylation of rhodopsin

1 reference

12 December 2020

Inflammation and insulin resistance

1 reference

12 December 2020

10.1007/S11033-010-0389-3

Identifiers

DOI

1 reference

23 August 2017

1 reference